Back to search
Deleterious BARD1 Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Deleterious BARD1 Gene Mutation trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Deleterious BARD1 Gene Mutation trials you may qualify forThis phase II trial studies how well surgery works in preventing ovarian cancer in patients with genetic mutations at risk of ovarian cancer. Risk reducing salp…
This study will examine the combination of pembrolizumab and olaparib in three populations. * Cohort 1: aBC patients with a germline mutation in BRCA1 or BRCA2…
A Phase 2, open-label, single-arm trial to evaluate the response of rucaparib in participants with various solid tumors and with deleterious mutations in Homolo…